Radiation 'Priming' could supercharge lung cancer treatment
NCT ID NCT07523464
First seen Apr 23, 2026 · Last updated May 25, 2026 · Updated 6 times
Summary
This early-phase study tests whether giving a precise, low dose of radiation to the center of a lung tumor can 'prime' the immune system before standard chemoradiation and immunotherapy. About 24 adults with advanced, inoperable lung cancer will receive this experimental radiation, followed by one round of immunotherapy, then standard treatment. The main goal is to see if this approach is safe and does not cause severe side effects or treatment delays.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIOTHERAPY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.